Global Diabetes Devices Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Insulin is a hormone that is being secreted by the pancreas. Diabetes is a chronic disease which is caused either in case if the body is unable to use the insulin pancreas are producing, or no insulin is being secreted at all. Diabetic devices are used to diagnose, monitor and manage type I or type II diabetes diseases.

Global Diabetes Devices Market Segments Size & Growth:

Global Diabetes Devices Market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% during the forecast timeline 2018-2024. Diabetes devices are used for both monitorings as well as for treatment purposes. As the number of diabetic affected people are increasingly increasing to a larger extent, this market has got wider expansion regarding market forecast and growth. In addition to that increase in the population of obese people, the rise in rapid industrialisation and urbanisation are considered to be the boosting factors for the growth of global diabetes devices market. Moreover, innovation of new technologies for insulin injection is a primary key factor for the moderate growth of the market throughout the forecast period. However, lack of awareness regarding diabetes, availability for alternative treatments, the high cost of diabetes devices, the disparity in reimbursement, the rise in the number of oral drugs and many other factors are considered to be the main challenges for the growth of the overall market.

Global Diabetes Devices Market Segments Share:

The overall growth of the market for Diabetes Devices is considered as the collaboration of individual growths that occurred at various segments of the market. Depending upon the products available, the Diabetic Devices are sectored as a device used for monitoring and devices used for treatments. Various products that are available include, Self-monitoring Blood Glucose Meters, Blood Glucose Testing Strips, Lancets, and Continuous Glucose Monitoring Devices, Insulin Delivery Devices Insulin Syringes, Insulin Pens, and Insulin Pumps, Diabetes Monitoring Software, and Artificial Pancreas System. Depending on the customer’s requirement, a wide variety of pens and pumps are available in the market. Among all, it was accounted previously that the market share was majorly hold Diabetes Monitoring Devices. Depending upon the distribution channels, the market is segmented as hospital pharmacies, retail pharmacies, online pharmacies, diabetes clinics and centres and many others. Hospital Pharmacies contribute a maximum share to the market of diabetes devices market regarding revenues. Also, increase the number of prescription and non-prescription diabetes care devices, it is estimated that online Pharmacies are also likely to increase throughout the forecast period.

Based on the end-users this market is segmented as hospitals, Clinics, Home Healthcare, Ambulatory care and others. Depending upon the geographical segmentation, North America followed by Europe is considered as a mega market for Diabetes Devices Market owing to advance healthcare infrastructure along with awareness in population regarding the treatment of diabetes and other associated diseases. It is expected that the Diabetes Devices Market in the Asia Pacific would be growing with a moderate CAGR throughout the forecast timeline as an increase in population, healthcare facilities, and developing economies are accounted in the regions of Asia Pacific like China, India, and others.

Global Diabetes Devices Market Trends:

• Medtronic and Mercy Will Share Data to Accelerate Medical Device Innovation
• Eli Lilly and Company Reveals Plan for Innovation Center that will help to accelerate new drug delivery and device innovation through external collaboration in Cambridge, Massachusetts

Global Diabetes Devices Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major key players in the Global Diabetes Devices Market are:

• Medtronic Public Limited Company
• Novo Nordisk A/S
• Sanofi S.A.
• Eli Lilly and Company
• Hoffmann-La Roche Ltd.
• Becton, Dickinson, and Company

Along with these companies, there were many other companies considered/cited in the report while analysing the Global Diabetes Devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.